LeMaitre Q1 sales $39.6M (+13% organic), EPS $0.27; guides FY $160-164M, closes French factory

LEMAITRE VASCULAR INC

2022-Q1 EPS reported $0.27 revenue$39,561,000

Q1 sales $39.6M, +10% YoY (+13% organic); net income $6.0M, +2%; EPS $0.27, -4%.
FY 2022 guidance: sales $160-164M (+5%/+8% org), EPS $1.10-$1.20; lowered due to stronger USD.
Quarterly dividend $0.125/share, payable June 2, 2022 to shareholders of record May 17, 2022.
Committed to close St. Etienne, France factory by June 30, 2022; ~$3.1M special charges in 2022, ~$1M annual op income benefit from 2023.
Agreed to buy out Korean distributor JiSang for $540k; direct-to-hospital in Korea starting January 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.